Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Microbiology and Biotechnology|August 31, 2017
Designing Signal Peptides for Efficient Periplasmic Expression of Human Growth Hormone in Escherichia coliMeisam Jeiranikhameneh, Farzaneh Moshiri, Soheil Keyhan Falasafi, et al.
Gastroenterology and Hepatology From Bed to Bench|December 2, 2014
Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinomaFarzaneh Moshiri, Elisa Callegari, Lucilla D'Abundo, et al.
Biotech (Basel (Switzerland))|February 20, 2026
TG221: An Experimental Model for Liver Cancer Prevention and Treatment ApproachesElisa Callegari, Angelo Michilli, Farzaneh Moshiri, et al.
Oncotarget|August 17, 2016
Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemiasArash Sattari, Hasan Siddiqui, Farzaneh Moshiri, et al.
Biotech (Basel (Switzerland))|February 20, 2026
Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma CellsAngelo Michilli, Cristian Bassi, Farzaneh Moshiri, et al.
Microbial Pathogenesis|May 4, 2020
HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platformMohammad Gholami, NeginHosseini Rouzbahani, SiamakMirab Samiee, et al.
Scientific Reports|August 9, 2024
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapyLucilla D'Abundo, Cristian Bassi, Elisa Callegari, et al.
Frontiers in Genetics|May 1, 2013
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAsLaura Lupini, Cristian Bassi, Manuela Ferracin, et al.
Plos One|September 27, 2013
Anti-tumor activity of a miR-199-dependent oncolytic adenovirusElisa Callegari, Bahaeldin K Elamin, Lucilla D'Abundo, et al.
Pageof 2